Apomorphine controlled release (Serina Therapeutics)

阿扑吗啡控释制剂 (Serina Therapeutics)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameApomorphine controlled release (Serina Therapeutics)
Drug Alias NamePOZ-apomorphineSER-252
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSerina Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSerina Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A